Exousia Bio, Inc. Additional Paid in Capital
Exousia Bio, Inc. (LMMY) had Additional Paid in Capital of $22.07 million as of 2026-02-28, per its 10-Q filed 2026-06-16.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2026-06-16
- 2026-02-28: Additional Paid in Capital $22.07M.
- 2025-11-30: Additional Paid in Capital $22.07M.
- 2025-08-31: Additional Paid in Capital $27.49K.
- 2025-05-31: Additional Paid in Capital $30.99K.
| Period end | Additional Paid in Capital |
|---|---|
| 2026-02-28 | $22.07M 10-Q · filed 2026-06-16 |
| 2025-11-30 | $22.07M 10-Q · filed 2026-03-17 |
| 2025-08-31 | $27.49K 10-Q · filed 2025-11-17 |
| 2025-05-31 | $30.99K 10-Q · filed 2026-06-16 |
| 2025-02-28 | $27.49K 10-Q · filed 2025-04-24 |
| 2024-11-30 | $27.49K 10-Q · filed 2025-01-10 |
| 2024-08-31 | $27.49K 10-Q · filed 2024-10-11 |
| 2024-05-31 | $27.49K 10-K · filed 2025-10-17 |
| 2024-02-29 | $27.49K 10-Q · filed 2024-04-15 |
| 2023-11-30 | $27.49K 10-Q · filed 2024-01-16 |
| 2023-08-31 | $27.49K 10-Q · filed 2023-10-11 |
| 2023-05-31 | $27.49K 10-K · filed 2024-08-30 |
| 2023-02-28 | $2.97K 10-Q · filed 2023-05-08 |
| 2022-05-31 | $0.00 10-K · filed 2023-09-01 |